Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Five Doses of Inhaled Indacaterol in Persistent Asthma
NCT01959412Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Nov 2013; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01959412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01959412.